16-54285217-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024336.3(IRX3):āc.664G>Cā(p.Gly222Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,607,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024336.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRX3 | NM_024336.3 | c.664G>C | p.Gly222Arg | missense_variant | 2/4 | ENST00000329734.4 | NP_077312.2 | |
IRX3 | XM_005256139.4 | c.664G>C | p.Gly222Arg | missense_variant | 2/4 | XP_005256196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRX3 | ENST00000329734.4 | c.664G>C | p.Gly222Arg | missense_variant | 2/4 | 1 | NM_024336.3 | ENSP00000331608.3 | ||
IRX3 | ENST00000558054.1 | c.72+567G>C | intron_variant | 2 | ENSP00000463991.1 | |||||
IRX3 | ENST00000558180.2 | n.443G>C | non_coding_transcript_exon_variant | 2/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151890Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000254 AC: 6AN: 235826Hom.: 0 AF XY: 0.0000313 AC XY: 4AN XY: 127788
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1455794Hom.: 0 Cov.: 39 AF XY: 0.0000124 AC XY: 9AN XY: 723786
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151890Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74186
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 25, 2023 | The c.664G>C (p.G222R) alteration is located in exon 2 (coding exon 2) of the IRX3 gene. This alteration results from a G to C substitution at nucleotide position 664, causing the glycine (G) at amino acid position 222 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at